The United States first recognized the importance of patents before its founding and authorized the granting of patents in Article One, section 8, clause 8 of the U.S. Constitution. The first patent law was passed several years later, in 1790. As such, U.S. patents have a history of over two hundred and thirty years. The […]

The post How to Enforce Software Patents appeared first on The Rapacke Law Group.

Pollen DeFi (https://pollen.id/), the decentralized protocol that facilitates ‘hivemind' weighting of asset pools that back up market-tradable tokens, today revealed their upcoming ‘Incentivised Beta' platform release and details on how the ‘DeFi 2.0' protocol will enable its unique community-managed financial instrument. The ‘Beta' release, which goes live in December, will initially enable users to contribute to the continual balancing and rebalancing of a singular central asset pool that will back up a tradable asset token. The protocol will be open to whitelisted users who can begin building community credibility (in the form of a ‘reputation' score), compete for a position on the community leaderboard, and, in turn, will have a chance to earn mainnet Pollen ($PLN) governance tokens. 

Pollen DeFi aims to push ‘DeFi' into the ‘DeFi 2.0' era by moving beyond institutional imitation and removing centralized “middlemen”; the platform instead empowers user-curated cryptocurrency asset pools that are constantly refined via a merit-based balancing of users' portfolio suggestions. Community members are rewarded for making good decisions and subsequently gain more influence over the dynamically-rebalancing portfolio.  Alternatively, users who would prefer to turn to more qualified traders (based on proven reputation, scored by the platform) can delegate their voting power accordingly. These ‘hivemind approved' asset portfolios then back up ‘asset pool tokens' listed as easily accessible financial instruments capable of outperforming market fluctuations.  

Boosted earlier this year by strategic backers, The Graph and AlphaBit, Pollen DeFi is focused on building the ultimate ‘crypto meritocracy'; the salient, DAO-driven ‘DeFi 2.0' experience leans on the fact that the leadership team merely creates and hones the core technology and UI, ensures platform security, and facilitates user governance and ease of accessibility, while the diversity of opportunities presented within the financial instrument itself result from decentralized, community-contributed portfolio suggestions. Pollen DeFi is powered by two new tokenized assets built specifically with DeFi 2.0 in mind, the Pollen ($PLN) governance token and the native Portfolio Asset Index token ($PAI) which is backed by the total value locked (TVL) of the first and core asset pool on the platform.  Other crypto-communities, influencers, and even top-ranking Pollen DeFi users will be able to propose additional asset pools that will be continually re-balanced by user proposals and support new asset-backed tokens, similar to the $PAI token.

Pollen DeFi's move from Alpha to Beta with a dramatically upgraded protocol design is supported by an already strong community of followers wishing to begin the process of actively contributing to the balancing of the asset pool. Pollen DeFi's open-source protocol and merit-based system empowers the brightest minds in its community and incentivizes them to continually contribute. This means that $PAI token is backed by a continually rebalanced and optimized asset pool which aims to out-smart market fluctuations with overall global community intelligence ideal for the 24/7 nature of the cryptocurrency market.

Pollen DeFi Project Lead and Co-Founder, Philip Verrien, explained, “Our focus has been on rebuilding asset management from the ground up; reducing risk and volatility, while also maximizing yield and creating dynamic opportunity for anyone, regardless of their experience level; [Pollen DeFi] aims to be the embodiment of what we believe will be the next step in DeFi, and reflect the core principles of truly decentralized finance.” Pollen DeFi's community is at the center of it all; Verrien and his team have designed Pollen DeFi to be powerful and easily accessible not only for the experienced crypto traders hoping to receive community accolades and earn $PLN token rewards for sharing their alchemic index ratios, but also, for those crypto-newcomers who are more familiar with curated asset indexes from TradFi and retail crypto environments consisting of pre-vetted coins and tokens - these users will be able to use Pollen ($PLN) governance token or hold $PAI asset pool token to easily be a part of the secure and well-tuned, ‘hivemind-approved' asset portfolio. 

Pollen DeFi focuses on user participation and utility. It is designed to tackle governance and centralization issues commonplace in today's DeFi ecosystem. Focusing heavily on developing community participation incentives, and processes that build toward true decentralization, using the hivemind to put the community in control.

The $PAI token will be the first index token to be launched on the platform with its value tied to the TVL of the core asset pool. $PAI is designed to be a less volatile asset that provides a safer way to participate in the DeFi ecosystem and is designed to weather any market storm as it will be dynamically managed by the community 24/7. $PLN, on the other hand, is the governance token that allows participants to interact with the platform and is rewarded to community members who actively manage the portfolio successfully or delegate to those that do (from a leaderboard). 

Beginning in December, whitelisted users will be able to actively contribute suggestions to Pollen DeFi's first community-managed portfolio and associated asset pool token, Portfolio Asset Index ($PAI); reputation points earned during this part-testnet, part-mainnet ‘Community Release Incentivised Beta' will be ported over as part of full mainnet launch in Q1 2022. This means that whitelisted early adopters who engage with Pollen's ‘Community Release Incentivised Beta' will appear on the leaderboard once the platform is fully live on mainnet.  The Pollen DeFi team will be releasing more information regarding the community release whitelist and details for those that can participate in the coming weeks, in the meantime anyone interested can join Pollen's telegram group (https://t.me/pollen_dao) or follow @PollenDeFi on twitter. 

For more information, please visit pollen.id.

####

About Pollen DeFi

Pollen DeFi (https://pollen.id/), is a first of its kind decentralized asset management ecosystem where the community builds and manages crypto asset portfolios together. Decentralized finance is designed to be by the people, for the people, and Pollen DeFi is acknowledging this by building the first, truly decentralized platform for managing tokenized asset pools. The merit-based DAO provides a reputation-based governance protocol with incentives that leverage the community's collective wisdom to curate asset pools. In this system, all users of the platform stand to benefit from the contribution of the best performing participants. Initially, the Pollen DeFi platform and its Pollen governance token ($PLN) will manage a single asset token, the Portfolio Asset Index ($PAI) token. The $PAI token will be managed 24-7 by the community and is designed to be a low volatility ‘DeFi Lego' which can be used in other protocols in the decentralized finance ecosystem. After Mainnet launch, other communities will be able to create and manage alternative asset tokens via the Pollen DeFi platform.

The new training is finally here, and the big day has finally come! We just finished releasing our latest and greatest training called HIPAA and Medical Cannabis Patients Released training (check it out here)… 🥳 Our new mastery training will not only share our PROVEN strategies but also give step-by-step details on how to execute...

The post [NEW] HIPAA and Medical Cannabis Patients “Freshly Released” appeared first on Green CulturED eLearning Solutions.

In 2021, the WIPO Nigeria Office launched the second WIPO National IP Essay Competition as part of its World Intellectual Property Day activities. Read the winning essay by Oyinkansola Komolafe entitled Intellectual property, SMEs and Economic Recovery in Nigeria.

Learn how to choose the best crosshair in Valorant in this Valorant crosshair guide. Tips for beginners and advanced players

Stand for Children, a nonprofit based in Portland, Oregon, has spent the last 25 years working to improve the lives of children through education through proven solutions that focus on equity and racial justice.  

 

The organization followed a Children’s Defense Fund rally in June 1996, drawing some 300,000 participants to Washington, D.C., – largest demonstration for children in U.S. history. 

 

Since 1999, the organization, which operates across nine states, has achieved over 209 state and local victories and leveraged over $6.7 billion in education investments to improve the lives of more than 5.6 million children. 

 

Lightspeed, whoseinstructional audio systems address classroom equity by ensuring all students can hear clearly, became a Stand partner in 2020.  

 

Can certain specific medical device details remain company know-how or protected trade secrets even if patents are pursued on the medical device?  Consider the Seventh Circuit’s commentary in its August 9, 2021 decision upholding a preliminary injunction in the Life Spine, Inc. v. Aegis Spine, Inc. case.  The preliminary injunction prohibits Aegis from selling or marketing its competing AccelFix product (shown below, right) until the case is resolved on the merits.

In 2019, Life Spine sued Aegis, a former distributor of Life Spine’s ProLift^® expandable spacers (shown below, left) used in spinal surgeries, for, among other things, misusing its trade secrets.

Aegis argued in appealing the preliminary injunction that the district court erred in concluding that information about the ProLift device could remain a protected trade secret after Life Spine patented, displayed, and sold the device to hospitals and surgeons.  However, the Seventh Circuit held that “Aegis does not come close to showing that [the district court’s] finding was clear error.”  The Seventh Circuit stated that Aegis had not proven that Life Spine’s patent materials disclose the “exact dimensions and measurements of every ProLift component.” In addition, the Seventh Circuit stated that “those who attend ProLift displays do not have unfettered access to the device” and that “the only purchasers of the ProLift are hospitals and surgeons, who purchase the device for use in scheduled surgeries.”

Regarding the patent materials, a figure of which is shown below, the Seventh Circuit noted that “Life Spine’s patent did not disclose the precise specifications of the ProLift” devices.  The Seventh Circuit recognized that such dimensions could only be learned by someone who has access to the device and sophisticated measurement technology.  As for public displays, the Seventh Circuit noted that Life Spine representatives supervise those who attend ProLift displays as they handle the devices.

Regarding sales of the ProLift device, the Seventh Circuit noted that Life Spine or its distributors ship the ProLift in sealed boxes and that the surgeries are overseen by Life Spine representatives or distributors.  The Seventh Circuit further noted that “it seems doubtful that the hospitals or surgeons purchasing the device . . . would secretly unpackage the device [and] measure all its components with specialized measurement technology” and that it “seems even more unlikely that a device would be removed from a patient’s body and then reverse engineered.”

Following this decision, the case will return to the United States District Court for the Northern District of Illinois to continue on the merits.

The post Medical Device Trade Secret Not Publicly Disclosed via Patenting, Displaying, and Selling Covered Product, 7th Cir. Affirms appeared first on Knobbe Medical.

Revelation Biosciences, Inc., a clinical-stage life sciences company focused on the development of immunologic‑based therapies for the prevention and treatment of disease, and Petra Acquisition, Inc., today announced they have entered into a definitive merger agreement for a business combination that will result in Revelation becoming a publicly-traded company.

  MeaWallet and Australian Settlements Limited partner up to bring eftpos digital payment technology to the Australian Mutual and Customer...

MeaWallet and Australian Settlements Limited partner up to bring eftpos digital payment technology to the Australian Mutual and Customer Owned Banking Sector Australian Settlements...

While dramatic increases in product demand may seem like a cannabis business owner’s dream, maintaining compliance with unstable and unstandardized cannabis regulations can bring...

In most respects, running a cannabis dispensary is just like running any other retail operation. You have customers coming to your store to...